Study Group: Ambien Prescribers (US)(?)
Council Members in this Study Group: 313
Request a survey with this Study Group
Leading Experts in this Study Group
Daniel Wynn, MDDirector, Clinical Research
Consultants In Neurology Ltd.
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...
Neurologist
Medford Neurological Clinic, Inc.
Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...
Josef Parvizi, MDAttending Neurologist
Stanford University Medical Center
Josef Parvizi, MD, PhD, is an Assistant Professor of Neurological Sciences at Stanford University. Dr. Parvizi has main interest in analyzing the design and results of new clinical trials, of medications or devices, in various fields of neurology. He has clinical expertise in Alzheimer's disease, neuropathic...
Obstetrician and Gynecologist
ALAN B PATTERSON MD, PA
Alan Patterson, MD, is an Obstetrician and Gynecologist in private practice. He was on the teaching staff at Methodist Hospital, Indianapolis, where he wrote many protocols for the residency program. In the past few years he has given lectures to colleges and communities on menopausal syndrome, endometriosis,...
President
PSS Clinical Research
Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia. He is the Medical Director of the Critical Care Unit at DeKalb Medical Center in Decatur, Medical Director of Southern Sleep Technologies and the Co-Director of two sleep disorders centers in the Atlanta...
John Litton Jr., MDChief Executive Officer and President
Litton Family Medicine, PC
J. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...
Rheumatologist
HEALTHCARE PARTNERS MEDICAL GROUP
Dipti Doshi, MD, is a board certified Rheumatologist at Health Care Partners Medical group, California. Dr. Doshi is also board certified in Internal Medicine. Her special interests are in rheumatoid arthritis, lupus, pain-related to scleroderma, fibromyalgia, and osteoarthritis. Dr. Doshi is interested...
Founder and Director
Institute for Integrative Psychiatry
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Physicians who Treat Insomnia (US) | 508 |
| Lunesta Prescribers (US) | 267 |
| Sonata Prescribers (US) | 152 |
| Ambien CR Prescribers (US) | 123 |
| Physicians who Treat Depression (US) | 365 |
| SSRI Prescribers (US) | 243 |
| Psychiatrists (US) | 1105 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
Most hospitals are financially built on their heart programs. The "agressive" medical arm is conservative by our standards yet as good as stents at far less cost. If this was truly pursued by large companies with TPA insurance plans, their overall cost would drop with large savings in healthcare costs....
The ACCORD trial results were no suprise to our diabetes practice. We have been heavy users of Byetta since launch in 2005, and have seen the same results in our population of > 2000 diabetics with over 700 on Byetta. Since the Simpson et al study in the Canadian Journal of Medicine (CMAJ 2006;174(2):169-74)...
While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.
-Pharmacogenetic tests have not made it into the treatment or assessment process for most physicians. -Until the cost for these tests become negligible -- or, included in the cost of a particular antidepressant -- psychopharmacogenetic testing will not make it into the mainstream.
“Personalized medical diagnositics” looks to be evolving as a high impact area in neuropsychiatric drug development. Such ‘genetic biomarker’ platforms, based on either pharmacogenetic profiles coming from DNA blueprints or gene products from a simple blood draw, aim to identify patients who are...
GLG InstituteSM Seminars with this Study Group's Leading Experts(?)
Recent Seminars
Webcasts
Most Common Company Types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- President
- Medical Director
- Director
- Physician - Division Head
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

